Abingdon, United Kingdom

Lisa Marie Frost

USPTO Granted Patents = 37 

 

 

Average Co-Inventor Count = 5.3

ph-index = 13

Forward Citations = 395(Granted Patents)


Location History:

  • Oxfordshire, GB (2019 - 2022)
  • Abingdon, GB (2011 - 2023)

Company Filing History:


Years Active: 2011-2025

Loading Chart...
Loading Chart...
Loading Chart...
37 patents (USPTO):

Title: Lisa Marie Frost: Innovator in Heart Failure Treatments

Introduction

Lisa Marie Frost, based in Abingdon, GB, is a prolific inventor with a remarkable portfolio of 37 patents. Her work primarily focuses on innovative therapeutic solutions, particularly in the field of cardiology. Her dedication and expertise have significantly contributed to the advancement of treatments for heart failure.

Latest Patents

Among her latest contributions to science and medicine are her patents on nitroxyl donors with an improved therapeutic index. The disclosed subject matter provides N-substituted hydroxylamine derivative compounds, pharmaceutical compositions, and kits that include these compounds. These innovations outline methods of using such compounds or pharmaceutical compositions specifically for treating heart failure, showcasing a significant step forward in cardiac care.

Career Highlights

Lisa has worked with esteemed organizations like Cardioxyl Pharmaceuticals, Inc. and The Johns Hopkins University. Her diverse experiences in these companies have helped her refine her research and development skills, leading to groundbreaking inventions in the pharmaceutical field.

Collaborations

Throughout her career, Lisa has collaborated with notable professionals in her field, including Frederick Arthur Brookfield and Stephen Martin Courtney. These partnerships have enabled her to combine expertise and innovation, resulting in effective solutions to complex medical challenges.

Conclusion

Lisa Marie Frost stands out as a leading inventor in her domain, with a substantial number of patents that reflect her commitment to improving patient care and outcomes. Her latest research into nitroxyl donors continues to pave the way for new therapeutic strategies in managing heart failure. As she moves forward in her career, the impact of her work will undoubtedly resonate within the medical community and beyond.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…